AIM: To examine fibroblast activation protein (FAP) expression in pancreatic ductal adenocarcinoma (PDAC) and to analyze its relationship with the clinicopathology of PDAC. METHODS: FAP expression was examined in 134 PDAC specimens by immunohistochemistry, and in four pancreatic cancer cell lines (SW1990, Miapaca-2, AsPC-1 and BxPC-3) by Western blotting assay. We also analyzed the association between FAP expression in PDAC cells and the clinicopathology of PDAC patients. RESULTS: The results showed that the FAP was ex-pressed in both stromal fibroblast cells (98/134, 73.1%) and carcinoma cells (102/134, 76.1%). All 4 pancreatic cancer cell lines expressed FAP protein at different levels. Protein bands corresponding to the proteolytically active 170-kDa seprase dimer and its 88-kDa seprase subunit were identified. Higher FAP expression in carcinoma cells was associated with tumor size (P < 0.001), fibrotic focus (P = 0.003), perineural invasion (P = 0.009) and worse clinical outcome (P = 0.0085). CONCLUSION: FAP is highly expressed in carcinoma cells and fibroblasts in PDAC tissues, and its expression is associated with desmoplasia and worse prognosis.
AIM: To examine fibroblast activation protein (FAP) expression in pancreatic ductal adenocarcinoma (PDAC) and to analyze its relationship with the clinicopathology of PDAC. METHODS:FAP expression was examined in 134 PDAC specimens by immunohistochemistry, and in four pancreatic cancer cell lines (SW1990, Miapaca-2, AsPC-1 and BxPC-3) by Western blotting assay. We also analyzed the association between FAP expression in PDAC cells and the clinicopathology of PDACpatients. RESULTS: The results showed that the FAP was ex-pressed in both stromal fibroblast cells (98/134, 73.1%) and carcinoma cells (102/134, 76.1%). All 4 pancreatic cancer cell lines expressed FAP protein at different levels. Protein bands corresponding to the proteolytically active 170-kDa seprase dimer and its 88-kDa seprase subunit were identified. Higher FAP expression in carcinoma cells was associated with tumor size (P < 0.001), fibrotic focus (P = 0.003), perineural invasion (P = 0.009) and worse clinical outcome (P = 0.0085). CONCLUSION:FAP is highly expressed in carcinoma cells and fibroblasts in PDAC tissues, and its expression is associated with desmoplasia and worse prognosis.
Authors: Thomas Armstrong; Graham Packham; Lindsay B Murphy; Adrian C Bateman; John A Conti; David R Fine; Colin D Johnson; R Christopher Benyon; John P Iredale Journal: Clin Cancer Res Date: 2004-11-01 Impact factor: 12.531
Authors: J Niedermeyer; M Kriz; F Hilberg; P Garin-Chesa; U Bamberger; M C Lenter; J Park; B Viertel; H Püschner; M Mauz; W J Rettig; A Schnapp Journal: Mol Cell Biol Date: 2000-02 Impact factor: 4.272
Authors: Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari Journal: World J Gastroenterol Date: 2011-02-21 Impact factor: 5.742
Authors: M J Scanlan; B K Raj; B Calvo; P Garin-Chesa; M P Sanz-Moncasi; J H Healey; L J Old; W J Rettig Journal: Proc Natl Acad Sci U S A Date: 1994-06-07 Impact factor: 11.205
Authors: S Mathew; M J Scanlan; B K Mohan Raj; V V Murty; P Garin-Chesa; L J Old; W J Rettig; R S Chaganti Journal: Genomics Date: 1995-01-01 Impact factor: 5.736
Authors: Cuixia Cai; Rong Shi; Yuan Gao; Jun Zeng; Min Wei; Handuo Wang; Wenling Zheng; Wenli Ma Journal: Oncol Lett Date: 2015-09-23 Impact factor: 2.967
Authors: Paulette Mhawech-Fauceglia; Li Yan; Maryam Sharifian; Xing Ren; Song Liu; Grace Kim; Simon A Gayther; Tanja Pejovic; Kate Lawrenson Journal: Cancer Microenviron Date: 2014-10-21
Authors: Cole R Drifka; Jo Tod; Agnes G Loeffler; Yuming Liu; Gareth J Thomas; Kevin W Eliceiri; W John Kao Journal: Mod Pathol Date: 2015-09-04 Impact factor: 7.842